[1]
Stein E, Ebeling P, Shane E. Post-transplantation osteoporosis. Endocrinology and metabolism clinics of North America. 2007 Dec:36(4):937-63; viii
[PubMed PMID: 17983930]
[2]
Jalava T, Sarna S, Pylkkänen L, Mawer B, Kanis JA, Selby P, Davies M, Adams J, Francis RM, Robinson J, McCloskey E. Association between vertebral fracture and increased mortality in osteoporotic patients. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2003 Jul:18(7):1254-60
[PubMed PMID: 12854835]
[3]
Bjøro K, Brandsæter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E. Secondary Osteoporosis in Liver Transplant Recipients: a Longitudinal Study in Patients With and Without Cholestatic Liver Disease. Scandinavian journal of gastroenterology. 2003 Mar:38(3):320-327. doi: 10.1080/00365520310000681a. Epub
[PubMed PMID: 28248598]
[4]
Yu TM, Lin CL, Chang SN, Sung FC, Huang ST, Kao CH. Osteoporosis and fractures after solid organ transplantation: a nationwide population-based cohort study. Mayo Clinic proceedings. 2014 Jul:89(7):888-95. doi: 10.1016/j.mayocp.2014.02.017. Epub 2014 May 5
[PubMed PMID: 24809760]
[5]
Floreani A, Mega A, Tizian L, Burra P, Boccagni P, Baldo V, Fagiuoli S, Naccarato R, Luisetto G. Bone metabolism and gonad function in male patients undergoing liver transplantation: a two-year longitudinal study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2001:12(9):749-54
[PubMed PMID: 11605741]
[6]
Smets YF, de Fijter JW, Ringers J, Lemkes HH, Hamdy NA. Long-term follow-up study on bone mineral density and fractures after simultaneous pancreas-kidney transplantation. Kidney international. 2004 Nov:66(5):2070-6
[PubMed PMID: 15496181]
[7]
Mikuls TR, Julian BA, Bartolucci A, Saag KG. Bone mineral density changes within six months of renal transplantation. Transplantation. 2003 Jan 15:75(1):49-54
[PubMed PMID: 12544870]
[8]
Cohen A, Sambrook P, Shane E. Management of bone loss after organ transplantation. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2004 Dec:19(12):1919-32
[PubMed PMID: 15537434]
[9]
Ball AM, Gillen DL, Sherrard D, Weiss NS, Emerson SS, Seliger SL, Kestenbaum BR, Stehman-Breen C. Risk of hip fracture among dialysis and renal transplant recipients. JAMA. 2002 Dec 18:288(23):3014-8
[PubMed PMID: 12479766]
[10]
Shane E, Rivas M, Staron RB, Silverberg SJ, Seibel MJ, Kuiper J, Mancini D, Addesso V, Michler RE, Factor-Litvak P. Fracture after cardiac transplantation: a prospective longitudinal study. The Journal of clinical endocrinology and metabolism. 1996 May:81(5):1740-6
[PubMed PMID: 8626827]
[11]
Ebeling PR. Approach to the patient with transplantation-related bone loss. The Journal of clinical endocrinology and metabolism. 2009 May:94(5):1483-90. doi: 10.1210/jc.2009-0205. Epub
[PubMed PMID: 19420272]
[12]
Ramsey-Goldman R, Dunn JE, Dunlop DD, Stuart FP, Abecassis MM, Kaufman DB, Langman CB, Salinger MH, Sprague SM. Increased risk of fracture in patients receiving solid organ transplants. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 1999 Mar:14(3):456-63
[PubMed PMID: 10027911]
[13]
Ninkovic M, Love SA, Tom B, Alexander GJ, Compston JE. High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation. Calcified tissue international. 2001 Dec:69(6):321-6
[PubMed PMID: 11800228]
[14]
Díez-Perez A, Nogués X, Mellibovsky L, Carbonell J. Bone mass, vitamin D deficiency and hyperparathyroidism in congestive heart failure. The American journal of medicine. 1998 Oct:105(4):358-9
[PubMed PMID: 9809702]
[15]
Canalis E, Delany AM. Mechanisms of glucocorticoid action in bone. Annals of the New York Academy of Sciences. 2002 Jun:966():73-81
[PubMed PMID: 12114261]
[16]
Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. The Journal of clinical investigation. 1998 Jul 15:102(2):274-82
[PubMed PMID: 9664068]
[17]
Chrousos GP, Torpy DJ, Gold PW. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications. Annals of internal medicine. 1998 Aug 1:129(3):229-40
[PubMed PMID: 9696732]
[18]
Martin P, DiMartini A, Feng S, Brown R Jr, Fallon M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology (Baltimore, Md.). 2014 Mar:59(3):1144-65
[PubMed PMID: 24716201]
Level 1 (high-level) evidence
[19]
. Erratum: Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2017;7:1-59. Kidney international supplements. 2017 Dec:7(3):e1. doi: 10.1016/j.kisu.2017.10.001. Epub 2017 Nov 17
[PubMed PMID: 30681074]
Level 1 (high-level) evidence
[20]
Cohen A, Shane E. Osteoporosis after solid organ and bone marrow transplantation. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2003 Aug:14(8):617-30
[PubMed PMID: 12908095]
[21]
Tauchmanovà L, Colao A, Lombardi G, Rotoli B, Selleri C. Bone loss and its management in long-term survivors from allogeneic stem cell transplantation. The Journal of clinical endocrinology and metabolism. 2007 Dec:92(12):4536-45
[PubMed PMID: 17911175]
[22]
Maalouf NM, Shane E. Osteoporosis after solid organ transplantation. The Journal of clinical endocrinology and metabolism. 2005 Apr:90(4):2456-65
[PubMed PMID: 15623822]
[23]
Costanzo MR, Dipchand A, Starling R, Anderson A, Chan M, Desai S, Fedson S, Fisher P, Gonzales-Stawinski G, Martinelli L, McGiffin D, Smith J, Taylor D, Meiser B, Webber S, Baran D, Carboni M, Dengler T, Feldman D, Frigerio M, Kfoury A, Kim D, Kobashigawa J, Shullo M, Stehlik J, Teuteberg J, Uber P, Zuckermann A, Hunt S, Burch M, Bhat G, Canter C, Chinnock R, Crespo-Leiro M, Delgado R, Dobbels F, Grady K, Kao W, Lamour J, Parry G, Patel J, Pini D, Towbin J, Wolfel G, Delgado D, Eisen H, Goldberg L, Hosenpud J, Johnson M, Keogh A, Lewis C, O'Connell J, Rogers J, Ross H, Russell S, Vanhaecke J, International Society of Heart and Lung Transplantation Guidelines. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2010 Aug:29(8):914-56. doi: 10.1016/j.healun.2010.05.034. Epub
[PubMed PMID: 20643330]
[24]
Lucey MR, Terrault N, Ojo L, Hay JE, Neuberger J, Blumberg E, Teperman LW. Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2013 Jan:19(1):3-26. doi: 10.1002/lt.23566. Epub
[PubMed PMID: 23281277]
Level 1 (high-level) evidence
[25]
Vautour LM, Melton LJ 3rd, Clarke BL, Achenbach SJ, Oberg AL, McCarthy JT. Long-term fracture risk following renal transplantation: a population-based study. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2004 Feb:15(2):160-7
[PubMed PMID: 14666400]
[26]
Wolpaw T, Deal CL, Fleming-Brooks S, Bartucci MR, Schulak JA, Hricik DE. Factors influencing vertebral bone density after renal transplantation. Transplantation. 1994 Dec 15:58(11):1186-9
[PubMed PMID: 7992360]
[27]
Kananen K, Volin L, Laitinen K, Alfthan H, Ruutu T, Välimäki MJ. Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate. The Journal of clinical endocrinology and metabolism. 2005 Jul:90(7):3877-85
[PubMed PMID: 15797959]
[28]
Crawford BA, Kam C, Pavlovic J, Byth K, Handelsman DJ, Angus PW, McCaughan GW. Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial. Annals of internal medicine. 2006 Feb 21:144(4):239-48
[PubMed PMID: 16490909]
Level 1 (high-level) evidence
[29]
Hardinger KL, Ho B, Schnitzler MA, Desai N, Lowell J, Shenoy S, Chapman W, Crippin JS. Serial measurements of bone density at the lumbar spine do not predict fracture risk after liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2003 Aug:9(8):857-62
[PubMed PMID: 12884200]
[30]
Mainra R, Elder GJ. Individualized therapy to prevent bone mineral density loss after kidney and kidney-pancreas transplantation. Clinical journal of the American Society of Nephrology : CJASN. 2010 Jan:5(1):117-24. doi: 10.2215/CJN.03770609. Epub 2009 Dec 3
[PubMed PMID: 19965527]
[31]
Shane E, Cohen A, Stein EM, McMahon DJ, Zhang C, Young P, Pandit K, Staron RB, Verna EC, Brown R, Restaino S, Mancini D. Zoledronic acid versus alendronate for the prevention of bone loss after heart or liver transplantation. The Journal of clinical endocrinology and metabolism. 2012 Dec:97(12):4481-90. doi: 10.1210/jc.2012-2804. Epub 2012 Sep 28
[PubMed PMID: 23024190]
[32]
Tauchmanovà L, Ricci P, Serio B, Lombardi G, Colao A, Rotoli B, Selleri C. Short-term zoledronic acid treatment increases bone mineral density and marrow clonogenic fibroblast progenitors after allogeneic stem cell transplantation. The Journal of clinical endocrinology and metabolism. 2005 Feb:90(2):627-34
[PubMed PMID: 15546907]
[33]
Stein EM, Ortiz D, Jin Z, McMahon DJ, Shane E. Prevention of fractures after solid organ transplantation: a meta-analysis. The Journal of clinical endocrinology and metabolism. 2011 Nov:96(11):3457-65. doi: 10.1210/jc.2011-1448. Epub 2011 Aug 17
[PubMed PMID: 21849532]
Level 1 (high-level) evidence
[34]
Shane E, Addesso V, Namerow PB, McMahon DJ, Lo SH, Staron RB, Zucker M, Pardi S, Maybaum S, Mancini D. Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation. The New England journal of medicine. 2004 Feb 19:350(8):767-76
[PubMed PMID: 14973216]
[35]
Sambrook P, Henderson NK, Keogh A, MacDonald P, Glanville A, Spratt P, Bergin P, Ebeling P, Eisman J. Effect of calcitriol on bone loss after cardiac or lung transplantation. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 2000 Sep:15(9):1818-24
[PubMed PMID: 10977001]
[36]
Stempfle HU, Werner C, Echtler S, Wehr U, Rambeck WA, Siebert U, Uberfuhr P, Angermann CE, Theisen K, Gärtner R. Prevention of osteoporosis after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. Transplantation. 1999 Aug 27:68(4):523-30
[PubMed PMID: 10480411]
Level 1 (high-level) evidence
[37]
Brunova J, Kratochvilova S, Stepankova J. Osteoporosis Therapy With Denosumab in Organ Transplant Recipients. Frontiers in endocrinology. 2018:9():162. doi: 10.3389/fendo.2018.00162. Epub 2018 Apr 17
[PubMed PMID: 29720961]
[38]
Bonani M, Frey D, Brockmann J, Fehr T, Mueller TF, Saleh L, von Eckardstein A, Graf N, Wüthrich RP. Effect of Twice-Yearly Denosumab on Prevention of Bone Mineral Density Loss in De Novo Kidney Transplant Recipients: A Randomized Controlled Trial. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2016 Jun:16(6):1882-91. doi: 10.1111/ajt.13692. Epub 2016 Feb 29
[PubMed PMID: 26713403]
Level 1 (high-level) evidence
[39]
Kobel C, Frey D, Graf N, Wüthrich RP, Bonani M. Follow-Up of Bone Mineral Density Changes in de novo Kidney Transplant Recipients Treated with Two Doses of the Receptor Activator of Nuclear Factor κB Ligand Inhibitor Denosumab. Kidney & blood pressure research. 2019:44(5):1285-1293. doi: 10.1159/000503066. Epub 2019 Oct 15
[PubMed PMID: 31614356]
[40]
Cejka D, Benesch T, Krestan C, Roschger P, Klaushofer K, Pietschmann P, Haas M. Effect of teriparatide on early bone loss after kidney transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2008 Sep:8(9):1864-70. doi: 10.1111/j.1600-6143.2008.02327.x. Epub
[PubMed PMID: 18786230]
[41]
Bianda T, Linka A, Junga G, Brunner H, Steinert H, Kiowski W, Schmid C. Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate. Calcified tissue international. 2000 Aug:67(2):116-21
[PubMed PMID: 10920215]
[42]
Braith RW, Conner JA, Fulton MN, Lisor CF, Casey DP, Howe KS, Baz MA. Comparison of alendronate vs alendronate plus mechanical loading as prophylaxis for osteoporosis in lung transplant recipients: a pilot study. The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 2007 Feb:26(2):132-7
[PubMed PMID: 17258146]
Level 3 (low-level) evidence